A detailed history of Boston Financial Mangement LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Boston Financial Mangement LLC holds 9,305 shares of BMY stock, worth $523,127. This represents 0.01% of its overall portfolio holdings.

Number of Shares
9,305
Previous 9,309 0.04%
Holding current value
$523,127
Previous $386,000 24.61%
% of portfolio
0.01%
Previous 0.01%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$39.66 - $51.75 $158 - $207
-4 Reduced 0.04%
9,305 $481,000
Q2 2024

Jul 29, 2024

SELL
$40.25 - $52.99 $109,681 - $144,397
-2,725 Reduced 22.64%
9,309 $386,000
Q1 2024

May 10, 2024

SELL
$47.98 - $54.4 $36,032 - $40,854
-751 Reduced 5.87%
12,034 $652,000
Q4 2023

Feb 12, 2024

SELL
$48.48 - $57.85 $20,410 - $24,354
-421 Reduced 3.19%
12,785 $655,000
Q3 2023

Nov 09, 2023

SELL
$57.89 - $64.73 $134,362 - $150,238
-2,321 Reduced 14.95%
13,206 $766,000
Q2 2023

Aug 07, 2023

BUY
$63.71 - $70.74 $84,033 - $93,306
1,319 Added 9.28%
15,527 $992,000
Q1 2023

May 12, 2023

SELL
$65.71 - $74.53 $114,006 - $129,309
-1,735 Reduced 10.88%
14,208 $984,000
Q4 2022

Jan 27, 2023

BUY
$68.48 - $81.09 $32,528 - $38,517
475 Added 3.07%
15,943 $0
Q3 2022

Nov 09, 2022

BUY
$0.13 - $76.84 $17 - $10,219
133 Added 0.87%
15,468 $1.1 Million
Q2 2022

Aug 08, 2022

BUY
$72.62 - $79.98 $13,289 - $14,636
183 Added 1.21%
15,335 $1.18 Million
Q1 2022

May 13, 2022

SELL
$61.48 - $73.72 $16,661 - $19,978
-271 Reduced 1.76%
15,152 $1.11 Million
Q4 2021

Feb 11, 2022

BUY
$53.63 - $62.52 $69,504 - $81,025
1,296 Added 9.17%
15,423 $962,000
Q1 2021

May 07, 2021

SELL
$59.34 - $66.74 $127,046 - $142,890
-2,141 Reduced 13.16%
14,127 $892,000
Q4 2020

Feb 10, 2021

SELL
$57.74 - $65.43 $17,322 - $19,629
-300 Reduced 1.81%
16,268 $1.01 Million
Q3 2020

Nov 12, 2020

SELL
$57.43 - $63.64 $35,893 - $39,775
-625 Reduced 3.64%
16,568 $999,000
Q2 2020

Aug 10, 2020

SELL
$54.82 - $64.09 $55,916 - $65,371
-1,020 Reduced 5.6%
17,193 $1.01 Million
Q1 2020

May 05, 2020

SELL
$46.4 - $67.43 $26,030 - $37,828
-561 Reduced 2.99%
18,213 $1.02 Million
Q4 2019

Feb 05, 2020

SELL
$49.21 - $64.19 $31,149 - $40,632
-633 Reduced 3.26%
18,774 $1.21 Million
Q3 2019

Nov 08, 2019

SELL
$42.77 - $50.71 $4,277 - $5,071
-100 Reduced 0.51%
19,407 $984,000
Q2 2019

Jul 24, 2019

SELL
$44.62 - $49.34 $113,781 - $125,817
-2,550 Reduced 11.56%
19,507 $885,000
Q1 2019

Apr 25, 2019

SELL
$45.12 - $53.8 $35,509 - $42,340
-787 Reduced 3.45%
22,057 $1.05 Million
Q4 2018

Jan 31, 2019

SELL
$48.76 - $63.23 $201,476 - $261,266
-4,132 Reduced 15.32%
22,844 $1.19 Million
Q3 2018

Nov 02, 2018

BUY
$55.19 - $62.25 $320,212 - $361,174
5,802 Added 27.4%
26,976 $1.68 Million
Q2 2018

Aug 03, 2018

SELL
$50.53 - $62.98 $70,337 - $87,668
-1,392 Reduced 6.17%
21,174 $1.17 Million
Q1 2018

Apr 25, 2018

SELL
$59.92 - $68.98 $45,419 - $52,286
-758 Reduced 3.25%
22,566 $1.43 Million
Q4 2017

Feb 05, 2018

SELL
$59.94 - $65.35 $38,661 - $42,150
-645 Reduced 2.69%
23,324 $1.43 Million
Q3 2017

Oct 30, 2017

BUY
$55.23 - $63.74 $1.32 Million - $1.53 Million
23,969
23,969 $1.53 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Boston Financial Mangement LLC Portfolio

Follow Boston Financial Mangement LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Financial Mangement LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boston Financial Mangement LLC with notifications on news.